-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | 1.320% | 4.054% | -4.348% | -23.000% | 11.594% | -75.938% | - |
Sirona Biochem Corp. | 6.820% | -2.299% | -4.494% | -52.567% | -34.615% | -78.261% | -83.591% |
Larimar Therapeutics Inc. | 12.030% | 2.759% | 24.167% | 120.414% | 82.598% | -29.717% | -71.311% |
News
A Once-in-a-Generation Investment Opportunity: 1 Data Center Stock That Could Go Parabolic (Hint: not Nvidia)
Artificial intelligence (AI) is the biggest tailwind in the technology sector right now. Generative AI has myriad applications, and mega-cap-tech behemoths are leading innovation efforts across the
1 Small-Cap Chip Stock Just Tanked Nearly 30% -- Time to Buy?
Shares of small U.S.-based chip manufacturing start-up SkyWater Technologies (NASDAQ: SKYT) initially tanked over 30% following its Q1 2024 earnings update. Shares have rebounded a bit since then
Nvidia Is Leading the Artificial Intelligence (AI) Charge, But These 2 Companies Are Rising Stars
AI chip leader Nvidia (NASDAQ: NVDA) will no doubt have very strong growth over the next year-plus. But while the chip designers like Nvidia and its would-be competitors garner a lot of headlines